2026-04-29T22:45:41Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/85932025-05-23T14:34:38Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609
Repisalud
author
Garcia, Maria Teresa
author
Blázquez, María Amparo
author
Ferrandiz-Avellano, Maria-Jose
author
Sanz, María Jesús
author
Silva-Martín, Noella
author
Hermoso, Juan A
author
de la Campa, Adela G
funder
Comunidad de Madrid (España)
funder
Ministerio de Ciencia e Innovación (España)
funder
Instituto de Salud Carlos III
2019-11-14T11:21:18Z
2019-11-14T11:21:18Z
2011-02-25
J Biol Chem. 2011 Feb 25;286(8):6402-13. doi: 10.1074/jbc.M110.148148. Epub 2010 Dec 17.
10.1074/jbc.M110.148148
1083-351X
0021-9258
The Journal of biological chemistry
21169356
http://hdl.handle.net/20.500.12105/8593
Streptococcus pneumoniae has two type II DNA-topoisomerases (DNA-gyrase and DNA topoisomerase IV) and a single type I enzyme (DNA-topoisomerase I, TopA), as demonstrated here. Although fluoroquinolones target type II enzymes, antibiotics efficiently targeting TopA have not yet been reported. Eighteen alkaloids (seven aporphine and 11 phenanthrenes) were semisynthesized from boldine and used to test inhibition both of TopA activity and of cell growth. Two phenanthrenes (seconeolitsine and N-methyl-seconeolitsine) effectively inhibited both TopA activity and cell growth at equivalent concentrations (∼17 μM). Evidence for in vivo TopA targeting by seconeolitsine was provided by the protection of growth inhibition in a S. pneumoniae culture in which the enzyme was overproduced. Additionally, hypernegative supercoiling was observed in an internal plasmid after drug treatment. Furthermore, a model of pneumococcal TopA was made based on the crystal structure of Escherichia coli TopA. Docking calculations indicated strong interactions of the alkaloids with the nucleotide-binding site in the closed protein conformation, which correlated with their inhibitory effect. Finally, although seconeolitsine and N-methyl-seconeolitsine inhibited TopA and bacterial growth, they did not affect human cell viability. Therefore, these new alkaloids can be envisaged as new therapeutic candidates for the treatment of S. pneumoniae infections resistant to other antibiotics.
eng
New alkaloid antibiotics that target the DNA topoisomerase I of Streptococcus pneumoniae
research article
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
URL
https://repisalud.isciii.es/bitstreams/02188351-9743-48b3-a7b0-92f6cbd7057c/download
File
MD5
ccba7ac8468382b5a4dfe56cf9345d23
218251
application/pdf
NewAlkaloidAntibioticsThat_2010.pdf
URL
https://repisalud.isciii.es/bitstreams/05979c28-70d9-4ff5-8e87-8e064ad23ef9/download
File
MD5
e1ff79fff6c40e5a841c91b5855f596f
7490
application/pdf
NewAlkaloidAntibioticsThat_2010_Figure 3.pdf
URL
https://repisalud.isciii.es/bitstreams/094f7e9c-e9c7-482e-a436-fd59ef9ff99e/download
File
MD5
aeab283eda1401289fa21b8016e31735
87245
application/pdf
NewAlkaloidAntibioticsThat_2010_Figure 4 Rev2.pdf
URL
https://repisalud.isciii.es/bitstreams/9996823c-7d58-41a1-9a6f-5ec4a7a58093/download
File
MD5
1b46ef7ed901641feb6014d1e97d67b5
46385
application/pdf
NewAlkaloidAntibioticsThat_2010_Figure 5 Rev2.pdf
URL
https://repisalud.isciii.es/bitstreams/8a211b74-7f7c-4ec4-8432-9fba5e17b644/download
File
MD5
b1fc448cdbc39e379967dd8834bc6c15
52075
application/pdf
NewAlkaloidAntibioticsThat_2010_Figure 6 Rev 2.pdf
URL
https://repisalud.isciii.es/bitstreams/4e10f79f-3df0-4dff-a064-5838acb60e82/download
File
MD5
6dce90506802c83a933b6ae0608d7224
77985
application/pdf
NewAlkaloidAntibioticsThat_2010_Figure 7 Rev 2.pdf
URL
https://repisalud.isciii.es/bitstreams/89be6a12-8408-439f-a03c-0f3a3b22d88c/download
File
MD5
e27e7ea0c661ced852fc46fbd9b9c0c1
145067
application/pdf
NewAlkaloidAntibioticsThat_2010_Figure 8 Rev 2.pdf
URL
https://repisalud.isciii.es/bitstreams/e3194875-b2bd-46b0-835a-25f95fe6f306/download
File
MD5
5029834ea006028f4c484151638c1c4c
104814
application/pdf
NewAlkaloidAntibioticsThat_2010_Figure 9 Rev2.pdf
URL
https://repisalud.isciii.es/bitstreams/c9a63732-0e5d-42f8-8a5d-37189d8d637a/download
File
MD5
91c83b77c216904750d827971ff9afa2
53264
text/plain
NewAlkaloidAntibioticsThat_2010.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/3c8f0377-0c44-4a01-a8dd-29f1063e8b91/download
File
MD5
8b6c5d216eea190906a61cbff88c939a
222
text/plain
NewAlkaloidAntibioticsThat_2010_Figure 3.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/fb960be4-557f-4b0f-9aaa-f794167a65e7/download
File
MD5
81ed82ba81647d68cffb26be56d75193
202
text/plain
NewAlkaloidAntibioticsThat_2010_Figure 4 Rev2.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/d04ed314-aac3-465a-a71e-06dea217e362/download
File
MD5
b4a97ce42f0d3ac9a696adc5bb210af5
216
text/plain
NewAlkaloidAntibioticsThat_2010_Figure 5 Rev2.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/65b7b858-d49d-4d25-a840-2435a3472e53/download
File
MD5
05648b3bf62a2647ca9c6912a0f1763f
189
text/plain
NewAlkaloidAntibioticsThat_2010_Figure 6 Rev 2.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/290f6db6-e422-4874-b710-055b238b5dc1/download
File
MD5
118dda4218247cf8d31c947a20ed4e29
86
text/plain
NewAlkaloidAntibioticsThat_2010_Figure 7 Rev 2.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/488282d3-9996-471f-a06a-eb4698666b37/download
File
MD5
af54249a58e9d849dcb60ff8788ca666
6
text/plain
NewAlkaloidAntibioticsThat_2010_Figure 8 Rev 2.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/3b803117-446a-4fe9-b753-0fe5856b5ab2/download
File
MD5
68b329da9893e34099c7d8ad5cb9c940
1
text/plain
NewAlkaloidAntibioticsThat_2010_Figure 9 Rev2.pdf.txt